Related Experiment Videos
Antecedents of cerebral palsy in very low-birth weight infants
1Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Insights
Preventing cerebral palsy (CP) in very low birth weight (VLBW) infants involves targeting prenatal and neonatal factors, particularly intrauterine infections and cytokine cascades. Strategies may include blocking inflammatory responses and utilizing maternal corticosteroids.
Area of Science:
- Neonatal Neurology
- Developmental Pediatrics
- Perinatal Medicine
Background:
- Cerebral palsy (CP) is a significant concern for very low birth weight (VLBW) infants.
- Pathogenesis involves prenatal and neonatal factors, with intrauterine infection being a key prenatal risk.
- Cytokine cascades triggered by infections and other perinatal events may cause brain damage.
Purpose of the Study:
- To review research on preventing CP in VLBW infants.
- To identify key factors in CP pathogenesis.
- To explore potential preventive strategies based on current understanding.
Main Methods:
- Literature review of research from the last two decades.
- Analysis of factors contributing to CP development.
- Evaluation of potential therapeutic targets and interventions.
Main Results:
- Intrauterine infection is a primary prenatal factor in CP.
- Perinatal factors like infection, co-twin death, placental abruption, and cerebral ischemia can initiate damaging cytokine cascades.
- Preeclampsia's association with lower CP rates may stem from reduced intrauterine infection.
Conclusions:
- Preventing CP in VLBW infants requires addressing intrauterine infection and inflammatory pathways.
- Targeting cytokine cascades, possibly through blockade or promoting inhibitors, is a promising avenue.
- Maternal corticosteroids and thyroid hormone are potential preventive strategies.
Abstract:
Research from the last two decades provides directions for efforts to prevent CP in VLBW infants. The pathogenesis of CP seems to involve factors operating both during pregnancy and in the neonatal period. The most important prenatal factor appears to be intrauterine infection. Perinatal infection and other risk factors, such as the death of a co-twin, placental abruption, and cerebral ischemia, could trigger a cytokine cascade resulting in damage to the developing brain. The low frequency of intrauterine infection in mothers with preeclampsia might explain the apparent protective effect of this disorder. If the brain damage attributed to intrauterine infection and other risk factors involves cytokines as intermediates, then blockade of the proinflammatory cascade or promotion of endogenous inhibitors might prevent CP. Other potentially preventive strategies include corticosteroids given to mothers (but not those given to neonates) and thyroid hormone.